LEADER 01312oam  2200409   450 
001 9910707760103321
005 20161104102913.0
035   $a(CKB)5470000002466947
035   $a(OCoLC)962069481
035   $a(OCoLC)995470000002466947
035   $a(EXLCZ)995470000002466947
100   $a20161104d2011      ua             0
101 0 $aeng
135   $aurmn|||||||||
181   $2rdacontent
182   $2rdamedia
183   $2rdacarrier
200 10$aMemorandum report $eensuring that Medicare Part D reimbursement is limited to drugs provided for medically accepted indications
210  1$aWashington, D.C. :$cDepartment of Health and Human Services, Office of Inspector General,$d2011.
215   $a1 online resource (9 pages)
300   $a"Nov[ember] 14 2011."
300   $a"OEI-07-08-00152."
320   $aIncludes bibliographical references.
517   $aMemorandum report 
606   $aMedicare
606   $aPharmaceutical services insurance$zUnited States
606   $aDrugs$xPrescribing$zUnited States
615  0$aMedicare.
615  0$aPharmaceutical services insurance
615  0$aDrugs$xPrescribing
801  0$bGPO
801  1$bGPO
801  2$bGPO
906   $aBOOK
912   $a9910707760103321
996   $aMemorandum report$93436443
997   $aUNINA